Literature DB >> 16917198

Postmortem indices linking risk factors to cognition: results from the Religious Order Study and the Memory and Aging Project.

David A Bennett1.   

Abstract

We present data from the Religious Orders Study and the Memory and Aging Project linking risk factors to pathology and cognitive function. Both studies involve more than 1000 older persons who agreed to annual clinical evaluation and brain donation at death. Published findings from the studies to date suggest that the relationship between risk factors, pathology, and cognitive impairment is complex. In some cases, known neuropathologic indices mediate the association of risk factors to cognition. In other cases, risk factors modify the relation of pathology to cognition. Finally, some risk factors seem to be related to clinical Alzheimer disease and cognitive decline, even decline in episodic memory, in the absence of any association with amyloid plaques, neurofibrillary tangles, or other pathologic indices that can be identified and quantified at this time. The findings to date illustrate the kinds of insights that can be gained into mechanisms of disease through the incorporation of pathologic indices into well-designed, epidemiologic studies of aging and Alzheimer disease.

Entities:  

Mesh:

Year:  2006        PMID: 16917198     DOI: 10.1097/00002093-200607001-00009

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  28 in total

1.  Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.

Authors:  Ainie Soetanto; Robert S Wilson; Konrad Talbot; Ashley Un; Julie A Schneider; Mark Sobiesk; Jeremiah Kelly; Sue Leurgans; David A Bennett; Steven E Arnold
Journal:  Arch Gen Psychiatry       Date:  2010-05

2.  PAK inactivation impairs social recognition in 3xTg-AD Mice without increasing brain deposition of tau and Aβ.

Authors:  Dany Arsenault; Alexandre Dal-Pan; Cyntia Tremblay; David A Bennett; Matthieu J Guitton; Yves De Koninck; Susumu Tonegawa; Frédéric Calon
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

3.  Neuronal LR11/sorLA expression is reduced in mild cognitive impairment.

Authors:  Kristen L Sager; Joanne Wuu; Susan E Leurgans; Howard D Rees; Marla Gearing; Elliott J Mufson; Allan I Levey; James J Lah
Journal:  Ann Neurol       Date:  2007-12       Impact factor: 10.422

4.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

Review 5.  The intersection of amyloid beta and tau at synapses in Alzheimer's disease.

Authors:  Tara L Spires-Jones; Bradley T Hyman
Journal:  Neuron       Date:  2014-05-21       Impact factor: 17.173

6.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

Review 7.  Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

Authors:  S Negash; D A Bennett; R S Wilson; J A Schneider; S E Arnold
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

8.  Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.

Authors:  Todd E Golde; Lon S Schneider; Edward H Koo
Journal:  Neuron       Date:  2011-01-27       Impact factor: 17.173

9.  The effects of normal aging on myelinated nerve fibers in monkey central nervous system.

Authors:  Alan Peters
Journal:  Front Neuroanat       Date:  2009-07-06       Impact factor: 3.856

10.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.